levorphanol and Chemical-and-Drug-Induced-Liver-Injury

levorphanol has been researched along with Chemical-and-Drug-Induced-Liver-Injury* in 4 studies

Reviews

1 review(s) available for levorphanol and Chemical-and-Drug-Induced-Liver-Injury

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for levorphanol and Chemical-and-Drug-Induced-Liver-Injury

ArticleYear
Genetically determined oxidation polymorphism and drug hepatotoxicity. Study of 51 patients.
    Journal of hepatology, 1989, Volume: 8, Issue:2

    The influence of genetically determined oxidation polymorphism on drug hepatotoxicity has been poorly investigated and results are controversial. We studied drug oxidation capacity in 51 patients with hepatitis caused mainly by drugs undergoing oxidative metabolism, using dextromethorphan, a test compound recently proposed as a substitute for debrisoquine. Phenotyping was performed using the metabolic ratio (MR) calculated as MR = 0-10 h urinary output of dextromethorphan/0-10 h urinary output of dextrorphan (the main oxidative metabolite), after oral administration of 40 mg dextromethorphan hydrobromide. Dextromethorphan oxidation capacity was similar in patients and in 103 control subjects as judged by: (a) the prevalence of each phenotype (5.9% versus 3.9% for the poor metabolizer phenotype and 94.1% versus 96.1% for the extensive metabolizer phenotype; (b) the frequency distribution histograms of log metabolic ratio; (c) the mean values of dextromethorphan and dextrorphan urinary outputs and of log metabolic ratio for each phenotype. These results show that hepatotoxicity of several drugs, including amineptine, amodiaquine and Plethoryl, is related neither to an impairment in dextromethorphan oxidation capacity nor to an unusually high capacity to oxidize this drug.

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Cohort Studies; Dextromethorphan; Dextrorphan; Female; Humans; Levorphanol; Male; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic

1989
Nyquil-associated liver injury.
    The American journal of gastroenterology, 1989, Volume: 84, Issue:4

    Acetaminophen, a commonly used medication, is present in many over-the-counter remedies. In recent years, its potential to cause severe liver injury has been increasingly appreciated. Chronic abusers of alcohol may be particularly susceptible to hepatotoxicity from acetaminophen. We report two cases of unintentional liver injury associated with ingestion of Nyquil, a liquid cold remedy containing acetaminophen and 25% alcohol.

    Topics: Acetaminophen; Adult; Alcoholism; Chemical and Drug Induced Liver Injury; Dextromethorphan; Doxylamine; Drug Combinations; Ephedrine; Female; Humans; Levorphanol; Liver; Male; Middle Aged; Necrosis; Nonprescription Drugs; Promethazine; Pseudoephedrine; Pyridines

1989
Nyquil and acute hepatic necrosis.
    The New England journal of medicine, 1985, Jul-04, Volume: 313, Issue:1

    Topics: Acetaminophen; Adult; Alcoholism; Chemical and Drug Induced Liver Injury; Dextromethorphan; Doxylamine; Drug Combinations; Ephedrine; Humans; Hypnotics and Sedatives; Levorphanol; Male; Nonprescription Drugs; Promethazine; Pseudoephedrine; Pyridines

1985